First drug for Dupuytren's contracture approved by US FDA
03 February 2010
Malini Guha
Auxilium Pharmaceuticals' novel therapy Xiaflex (collagenase clostridium histolyticum) has become the first US-approved drug to treat a potentially debilitating hand condition known as Dupuytren's contracture. The launch of Xiaflex is planned for late March.
"Before the FDA approved Xiaflex, the...
Please Login to read the full article.
03 February 2010
Malini Guha
"Before the FDA approved Xiaflex, the...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Xiaflex for Dupuytren's positive in pilot using convenient multiple injections
- Asahi Kasei pays $15 million to Auxilium for rights to Dupuytren's, Peyronie's drug
- Pfizer gains European ok for Xiapex for Dupuytren's contracture
- US FDA panel to weigh anaesthesia use in children
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
